| Primary |
| Soft Tissue Disorder |
33.3% |
| Surgery |
14.6% |
| Therapeutic Procedure |
14.6% |
| Breast Reconstruction |
6.5% |
| Skin Graft |
4.9% |
| Skin Implant |
4.1% |
| Transplant |
4.1% |
| Breast Prosthesis Implantation |
3.3% |
| Hernia Repair |
2.4% |
| Breast Cosmetic Surgery |
1.6% |
| Plastic Surgery |
1.6% |
| Skin Operation |
1.6% |
| Therapeutic Skin Care Topical |
1.6% |
| Skin Implant |
0.8% |
| Dental Operation |
0.8% |
| Ill-defined Disorder |
0.8% |
| Oral Disorder |
0.8% |
| Rotator Cuff Repair |
0.8% |
| Tendon Operation |
0.8% |
| Tendon Repair |
0.8% |
|
| Infection |
10.5% |
| Post Procedural Infection |
8.8% |
| Product Quality Issue |
8.8% |
| Swelling |
7.0% |
| Pyrexia |
6.1% |
| Staphylococcal Infection |
6.1% |
| Graft Infection |
5.3% |
| Pseudomonas Infection |
5.3% |
| Pseudomonas Test Positive |
4.4% |
| Skin Graft Infection |
4.4% |
| Staphylococcus Test Positive |
4.4% |
| Pharmaceutical Product Complaint |
3.5% |
| Postoperative Wound Infection |
3.5% |
| Seroma |
3.5% |
| Surgical Procedure Repeated |
3.5% |
| Wound Dehiscence |
3.5% |
| Wound Drainage |
3.5% |
| Graft Complication |
2.6% |
| Mycobacterium Fortuitum Infection |
2.6% |
| No Adverse Event |
2.6% |
|
| Secondary |
| Soft Tissue Disorder |
33.8% |
| Surgery |
23.5% |
| Therapeutic Procedure |
10.3% |
| Breast Prosthesis Implantation |
5.9% |
| Skin Implant |
5.9% |
| Breast Reconstruction |
4.4% |
| Dental Operation |
4.4% |
| Plastic Surgery |
2.9% |
| Skin Graft |
2.9% |
| Ill-defined Disorder |
1.5% |
| Tendon Operation |
1.5% |
| Tendon Repair |
1.5% |
| Transplant |
1.5% |
|
| Infection |
12.0% |
| Product Quality Issue |
10.0% |
| Graft Infection |
6.0% |
| Post Procedural Complication |
6.0% |
| Post Procedural Infection |
6.0% |
| Postoperative Infection |
6.0% |
| Pseudomonas Infection |
6.0% |
| Surgical Procedure Repeated |
6.0% |
| Implant Site Swelling |
4.0% |
| Mycobacterium Fortuitum Infection |
4.0% |
| Pharmaceutical Product Complaint |
4.0% |
| Serratia Test Positive |
4.0% |
| Skin Graft |
4.0% |
| Skin Graft Infection |
4.0% |
| Staphylococcal Infection |
4.0% |
| Therapeutic Product Contamination |
4.0% |
| Wound Drainage |
4.0% |
| Bacterial Test Positive |
2.0% |
| Breast Infection |
2.0% |
| Candida Test Positive |
2.0% |
|
| Concomitant |
|
| Pseudomonas Test Positive |
100.0% |
|
